Idenix, Janssen work on hepatitis C treatments

01/31/2013 | Pharmaceutical Business Review Online

Janssen Pharmaceuticals and Idenix Pharmaceuticals are working together on clinical development of direct-acting antiviral combination treatments for hepatitis C virus. The collaboration covers a drug-drug interaction study, followed by a midstage trial. The trials will be conducted by Idenix.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX